Philip Wong, joined the firm in 2017 following the acquisition of Breton Hill Capital Ltd (BHC). Philip is a Quantitative Investment Analyst on the Quantitative Research and Development team and supports research and systems development initiatives. He brings extensive skills in software development and data analysis. Prior to BHC, Philip played an important role in implementing and optimizing the imaging pipeline for a variety of medical imaging systems. Philip holds both an MSc and a BMSc (Hons.) in Medical Biophysics from the University of Western Ontario.